Lloyd M. Segal

130 posts

Lloyd M. Segal banner
Lloyd M. Segal

Lloyd M. Segal

@LM_Segal

Biotechnology and healthcare leader, advisor and investor.

Montreal & Boston Katılım Ağustos 2017
154 Takip Edilen192 Takipçiler
Lloyd M. Segal
Lloyd M. Segal@LM_Segal·
Excited to have Steven’s Stein’s wisdom and experience added to our Board today!
Repare Therapeutics@RepareRx

Please join @RepareRx in welcoming Dr. Steven H. Stein to our Board of Directors, effective June 17, 2024. Dr. Stein currently serves as the Chief Medical Officer of Incyte Corporation, a position he has held since March 2015.

English
0
0
1
86
Lloyd M. Segal
Lloyd M. Segal@LM_Segal·
Thrilled to have @FoundationATCG as a partner in helping us genomically match the patients who will most benefit from our new medicines! #precisiononcology #syntheticlethality
Repare Therapeutics@RepareRx

We are collaborating with @FoundationATCG to deliver genomic profiling to patients in our lunresertib clinical trials and beyond. We are thrilled to take this next step with potential to develop a companion diagnostic and expand access to clinical trial sites for lunresertib.

English
0
0
2
112
Lloyd M. Segal retweetledi
Harley Finkelstein
Harley Finkelstein@harleyf·
Today, @cafreeland is introducing a motion to increase the capital gains inclusion rate in Canada. This isn't a wealth tax — it's a tax on innovation and risk-taking. Investing in new products or ideas is inherently risky. Entrepreneurs need incentives, not penalties, to drive 🇨🇦 ​forward. This policy will disincentivize risk-taking and tax Canadian ambition at a time when we need more entrepreneurs, not fewer. The OECD predicts Canada will be the worst-performing advanced economy for per-person GDP growth until 2060. Killing our tax competitiveness is not the way to fix this. We need to change course, and fast.
English
86
278
1.2K
191.4K
Lloyd M. Segal retweetledi
Harley Finkelstein
Harley Finkelstein@harleyf·
We need to be doing everything we can to turn Canada into the best place for entrepreneurs to build 🇨🇦 What's proposed in the federal budget will do the complete opposite. Innovators and entrepreneurs will suffer and their success will be penalized -- this is not a wealth tax, it's a tax on innovation and risk taking. Our policy failures are America's gains. At a time when our country is facing critically low productivity and business investment our political leaders are failing our country's entrepreneurs. Please start listening to the people in the arena.
English
253
476
2.4K
313.6K
Lloyd M. Segal retweetledi
Repare Therapeutics
Repare Therapeutics@RepareRx·
First patient has been dosed with camonsertib in @Roche's Phase II global TAPISTRY trial treating patients with unresectable, locally advanced or metastatic #solidtumors. We are grateful to patients and investigators who are part of our shared mission. lnkd.in/eJ4jy8g3
Repare Therapeutics tweet media
English
1
3
11
782
Lloyd M. Segal
Lloyd M. Segal@LM_Segal·
Exciting new data today in @RepareRx lunre+camo combo, showing remarkable early efficacy signals and 50% RECIST response in 10 gyn patients at prelim RP2D and 60% OR in that initial group. Phenomenal new opportunity for patients & amazing work by the team and investigators!
Repare Therapeutics@RepareRx

At #Targets23, we presented positive initial data from Phase 1 MYTHIC clinical trial evaluating lunresertib alone and in combination with camonsertib. Join our live webcast today at 5:30pm ET, where we will be discussing the results. Read more: bit.ly/3ZU4oEd

English
0
1
4
1.6K
Lloyd M. Segal retweetledi
Lawrence H. Summers
Lawrence H. Summers@LHSummers·
In nearly 50 years of @Harvard affiliation, I have never been as disillusioned and alienated as I am today.
English
4.6K
6.5K
52.2K
15.3M
Lloyd M. Segal retweetledi
Repare Therapeutics
Repare Therapeutics@RepareRx·
Be sure to join @RepareRx live video webcast - which will feature additional updates from this week’s abstracts and highlight the significant potential we see for this combination - on Friday 10/13 at 5:30 p.m. ET: bit.ly/46AaNqk
English
0
1
1
395
Lloyd M. Segal retweetledi
Repare Therapeutics
Repare Therapeutics@RepareRx·
We look forward to presenting positive, new clinical data from our lunresertib + camonsertib MYTHIC combination trial, which includes a more mature data cut (Sept vs June in abstract) of more patients treated at clinically relevant doses next Friday at #Targets23.
Repare Therapeutics tweet media
English
1
4
10
2.2K
Lloyd M. Segal retweetledi
Roberto Bellini
Roberto Bellini@rbellini·
The uninformed perception is that biotech success can be easy. Find a great drug, run a trial with a great result, get bought out! Join me on a thread that explores the Bellus journey and how hard the path to drug development success can really be. $BLU $XBI
Roberto Bellini tweet media
English
7
28
137
38.7K
Lloyd M. Segal
Lloyd M. Segal@LM_Segal·
Looking forward to sharing important new @RepareRx data across multiple programs and achievements by the team, including a plenary talk by Dr Timothy Yap on the Lunre-Camo combination!
Repare Therapeutics@RepareRx

At the upcoming @AACR @theNCI @EORTC International Conference, Repare will present data from its ongoing Phase 1 MYTHIC clinical trial in a plenary session, in addition to multiple posters presentations. Learn more: tinyurl.com/bdhpdm4n #Targets23

English
0
0
8
428
Lloyd M. Segal
Lloyd M. Segal@LM_Segal·
Incredibly proud of this recognition of our work, the courage of the patients participating in our trials and the leadership, perseverance, dedication and innovation of the awesome, global team at @Repare and of our collaborators. #precisiononcology #syntheticlethality
Repare Therapeutics@RepareRx

Thank you to @BIOTECanada for naming Repare as the 2023 Gold Leaf Award for Top Established Biotech Company of the Year! We’re thrilled to be chosen and honored to join an impressive group of previous winners in the category.

English
1
0
6
1.4K
Lloyd M. Segal retweetledi
Repare Therapeutics
Repare Therapeutics@RepareRx·
Repare’s management team is participating in a fireside chat at the @MorganStanley Annual Global Healthcare Conference in NYC next week. We look forward to connecting in person! Click here to watch the webcast: tinyurl.com/frnzmtdv
Repare Therapeutics tweet media
English
0
1
2
414
Lloyd M. Segal
Lloyd M. Segal@LM_Segal·
A watershed Q for us as @Roche activates clinical starts of camonsertib globally + our multiple portfolio advances, with lunresertib data coming up + 2 new clinical programs. More great progress from amazing @RepareRx team + collaborators. #precisioncology #syntheticlethality
Repare Therapeutics@RepareRx

Today, we announced our second quarter 2023 financial results and provided a business update. Full press release with additional details: ir.reparerx.com/news-releases/… #precisiononcology #syntheticlethality $RPTX

English
0
0
7
623
Lloyd M. Segal
Lloyd M. Segal@LM_Segal·
Sorry - Daniel Lamarre! Wish Twitter had edits …
English
0
0
1
74
Lloyd M. Segal
Lloyd M. Segal@LM_Segal·
Exciting data today by Dr. Tim Yap + @RepareRx in #AACR2023 plenary session. Camonsertib, partnered with @Roche, continues to show high promise for patients with ovarian and other cancers. 👏Drs Maria Koehler, Mike Zinda and their teams! #precisiononcology #syntheticlethality
Repare Therapeutics@RepareRx

Today at #AACR23 Clinical Trials Plenary Session, Repare disclosed initial data from our ongoing Phase 1/2 TRESR and ATTACC clinical trials evaluating camonsertib in combination with three PARP inhibitors in patients with #solidtumors. Full presentation: tinyurl.com/ywvz72v4

English
0
0
10
2.5K

Keşfet

@FoundationATCG @cafreeland @Roche @RepareRx @Harvard @MorganStanley @Gyne_Oncology @elonmusk